Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05765474 · ClinicalTrials.gov registry record · NA

Motor Learning for Upper Limb Hemiparesis After Stroke

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT05765474: Completed NA study, sponsored by Columbia University.

NCT05765474 is a NA study that has completed, run by Columbia University. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05765474, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

The purpose of this research is to learn about practice conditions that may benefit stroke survivors when learning to use their more affected arm to perform a task. Participants will be randomized into two groups. Experimental and control groups will differ by one practice variable that will not be disclosed until completion of testing procedures. Participants will practice a motor task using both their more and less affected arms for two consecutive days. A Pre-Test will be administered on Day 1 before the training begins. Immediate Transfer of Learning will be administered on Day 2 after the completion of training. Delayed (24-hour) Retention and Transfer Tests will be administered on Day 3.

Primary Outcome

This is a 24-hour Retention Test of the trained motor task (the Scooping Task) that the participant practiced for 2 days. The participant is asked to use a spoon to scoop beans from one cup to another in an anterior-posterior direction, away from their body, for 30 seconds. One completed scoop occurs when at least one bean is transferred to the second cup. The score is the number of completed scoops that occur within 30 seconds. The participant will complete two blocks of five trials (30 seconds

Interventions

  • BEHAVIORAL Practice Variable
  • BEHAVIORAL No Practice Variable

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2023-03-22
Est. Completion 2024-02-16
Phase NA
Columbia University

958 total trials

What the finished NCT05765474 record still lists

NCT05765474 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Practice Variable is the first listed.

NCT05765474 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05765474 about?

NCT05765474 is a clinical study titled "Motor Learning for Upper Limb Hemiparesis After Stroke". The purpose of this research is to learn about practice conditions that may benefit stroke survivors when learning to use their more affected arm to perform a task. Participants will be randomized into two groups. Experimental and control groups will differ by one practice variable that will not be ...

What is the current status of trial NCT05765474?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2023-03-22. Estimated completion is 2024-02-16.

What interventions are being tested in trial NCT05765474?

The interventions under investigation include: Practice Variable (BEHAVIORAL), No Practice Variable (BEHAVIORAL).

Who is sponsoring clinical trial NCT05765474?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05765474's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05765474, the US trial registry maintained by the National Library of Medicine. NCT05765474 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.